Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,406 | 54,439 | 47,712 | 37,340 | 33,785 |
| Marketable Securities | 128,605 | 145,070 | 154,899 | 25,291 | 35,711 |
| Receivables | 23,258 | 16,841 | 18,266 | 12,617 | 10,509 |
| Inventories | 1,740 | 1,367 | 1,108 | 2,559 | 1,970 |
| TOTAL | $223,007 | $225,115 | $226,337 | $81,573 | $86,027 |
| Non-Current Assets | |||||
| PPE Net | 489 | 488 | 599 | 422 | 356 |
| Investments And Advances | 47,879 | 30,865 | 15,089 | 6,091 | 6,010 |
| Intangibles | 11,122 | 11,438 | 11,754 | 72,078 | 73,694 |
| Other Non-Current Assets | 2,234 | 2,210 | 2,498 | 12,544 | 12,040 |
| TOTAL | $61,724 | $45,001 | $29,940 | $91,135 | $92,100 |
| Total Assets | $284,731 | $270,116 | $256,277 | $172,708 | $178,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,598 | 11,072 | 15,842 | 17,819 | 25,456 |
| Other current liabilities | 13,550 | 14,599 | 12,465 | 8,568 | 8,189 |
| TOTAL | $39,277 | $26,112 | $28,832 | $26,976 | $34,065 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,928 | 61,310 | 60,692 | 60,090 | 59,504 |
| Other Non-Current Liabilities | 28,869 | 49,529 | 49,523 | 44,619 | 44,892 |
| TOTAL | $90,797 | $110,839 | $110,215 | $104,709 | $104,396 |
| Total Liabilities | $130,074 | $136,951 | $139,047 | $131,685 | $138,461 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,712 | 56,298 | 56,135 | 54,680 | 54,116 |
| Common Shares | 6 | 6 | 6 | 5 | 5 |
| Retained earnings | -422,060 | -434,225 | -433,681 | -508,388 | -505,289 |
| Other shareholders' equity | -747 | -2,399 | -2,411 | -65 | 648 |
| TOTAL | $154,657 | $133,165 | $117,230 | $41,023 | $39,666 |
| Total Liabilities And Equity | $284,731 | $270,116 | $256,277 | $172,708 | $178,127 |